KRAS and neoplasm: Comparisons of in vitro tumor cells with primary tumors of each subtype (MSS and MSI) have also shown similar frequencies of TP53, KRAS and APC mutations [12] and ploidy stem line [37], which further supports the conclusion that the in vitro system is a suitable experimental tool that closely reflect the in vivo situation.